
Human DEP domain-containing protein 1A 294-302, EYYELFVNI
Description
About Human DEP domain-containing protein 1A 294-302, EYYELFVNI
The Human DEP domain-containing protein 1A Peptide (IEDB: 2233757) is a high quality epitope peptide for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxicity or proliferation assays. The DEP domain-containing protein Peptide, H-EYYELFVNI-OH (Uniprot: Q5TB30 aa: 294-302) from JPT is produced under strict quality control and quality management.
Human DEP domain-containing protein 1A 294-302, EYYELFVNI - Specifications
- Peptide sequence: H-EYYELFVNI-OH
- Amount: 10 mg (10 x 1 mg)
- Purity: Trial Grade: each peptide purified to > 90% (HPLC/MS)
- Counterion: TFA
- Delivery Format: Freeze-dried in glass vial
- Application(s): T-cell Immunity
- Condition(s)/Topic(s): Cancer, Gastric cancer
- Standard Delivery Time: approx. 3 weeks
JPT’s Antigen Peptides
Find your antigen peptide and select the connected PepMix™ Peptide Pool for efficient immune monitoring, mapping of T cell epitopes or development of immunotherapy and vaccines. JPT Peptide Technologies has substantial, long-standing expertise in providing peptides, peptidomimetics, and proteins to the global scientific community. Our highly skilled and committed scientific staff ensures that the most appropriate methods and techniques are selected for every synthesis project. All our catalog peptides are provided with HPLC-MS analyses to confirm the identity and demonstrate the high quality of our peptides.
Not found what you are looking for? Take a look at our Custom Peptide Synthesis!
Benefits of JPT’s Antigen Peptides
- All peptides are made in Germany
- Bulk orders or custom peptide snythesis upon request
- Synthesis protocols designed to avoid toxic contaminants and side products
- Provision of freeze dried aliquots for enhanced stability
- Proven track record for applications in clinical studies
- Order the connected PepMix™ Peptide Pool with your peptide!
References
References for Human DEP domain-containing protein 1A 294-302, EYYELFVNI
References:
Read References with JPT’s Antigen Peptides
Human DEP domain-containing protein 1A 294-302, EYYELFVNI has been described in:
Exploratory open-label clinical study to determine the S-588410 cancer peptide vaccine-induced tumor-infiltrating lymphocytes and changes in the tumor microenvironment in esophageal cancer patients., Cancer Immunol Immunother, 2020 (PMID: 32500232)
A Pilot Study of Vaccine Therapy with Multiple Glioma Oncoantigen/Glioma Angiogenesis-Associated Antigen Peptides for Patients with Recurrent/Progressive High-Grade Glioma., J Clin Med, 2019 (PMID: 30791546)
Documentation
Documentation for Human DEP domain-containing protein 1A 294-302, EYYELFVNI
Properties
Properties of Human DEP domain-containing protein 1A 294-302, EYYELFVNI
Properties | Values |
---|---|
Application: | T-cell immunity |
Category: | Antigen Peptides |
Condition / Topic: | Cancer, Gastric cancer |
Layout: | Freeze-dried in glass vial |
Organism: | Human |
Protein Name: | DEP domain-containing protein |
Purity: | Trial Grade: each peptide purified to > 90% (HPLC/MS) |
Quantification: | No, Yes |
Further Information to Human DEP domain-containing protein 1A 294-302, EYYELFVNI
Information | Values |
---|---|
Sequence: | H-EYYELFVNI-OH |
Specifications: | 9mer peptide as TFA salt |